A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States (vol 21, pg 835, 2018)

被引：0
|
作者：
Nuijten, M. [1 ]
Marczewska, A. [1 ]
Torres, Araujo K. [1 ]
Rasouli, B. [1 ]
Perugini, M. [1 ]
机构：
[1] Ars Accessus Med, Amsterdam, Netherlands
来源：
JOURNAL OF MEDICAL ECONOMICS | 2018年 / 21卷 / 09期
关键词：
D O I：
10.1080/13696998.2018.1484647
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [1] A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States
    Nuijten, Mark
    Marczewska, Agnieszka
    Torres, Krysmaru Araujo
    Rasouli, Bahareh
    Perugini, Moreno
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (09) : 835 - 844
  • [2] Pegfilgrastim - a health economic model to assess overall cost-effectiveness
    Borget, Isabelle
    Di Palma, Mario
    Leonard, Robert
    EJHP PRACTICE, 2009, 15 (05): : 58 - 61
  • [3] OPTIFAST™ MEAL REPLACEMENT PROGRAM FOR THE TREATMENT OF OBESITY: A COST-EFFECTIVENESS ASSESSMENT FROM THE EMPLOYER PERSPECTIVE IN THE USA
    Perugini, M.
    Marczewska, A. M.
    Torres, Araujo K.
    Rasouli, B.
    Nuijten, M.
    VALUE IN HEALTH, 2018, 21 : S253 - S253
  • [4] DEVELOPMENT OF AN ECONOMIC MODEL TO ASSESS THE COST-EFFECTIVENESS OF NITISINONE AS A TREATMENT FOR ALKAPTONURIA IN THE UK
    McCarron, C.
    VALUE IN HEALTH, 2016, 19 (07) : A589 - A589
  • [5] Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States (vol 24, pg 29, 2018)
    Carlson, J. J.
    Guzauskas, G. F.
    Chapman, R. H.
    Synnott, P. G.
    Liu, S.
    Russo, E. T.
    Pearson, S. D.
    Brouwer, E. D.
    Ollendorf, D. A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 714 - 716
  • [6] Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B- cell lymphoma in the United States (vol 21, pg 1238, 2018)
    Roth, J. A.
    Sullivan, S. D.
    Lin, V. W.
    Bansala, A.
    Purdum, A. G.
    Navale, L.
    Cheng, P.
    Ramsey, S. R.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (12) : 1255 - 1255
  • [7] Cost-effectiveness of HIV testing and treatment in the United States
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    Weinstein, Milton C.
    Paltiel, A. David
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S248 - S254
  • [8] Designing and Testing of a Health-Economic Markov Model to Assess Cost-Effectiveness of the Treatment of Bipolar Disorder: TiBiPoMod
    Kleijburg, Anne
    Lokkerbol, Joran
    Wijnen, Ben
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2022, 25 : S20 - S20
  • [9] A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States
    Vanness, David J.
    Lomas, James
    Ahn, Hannah
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 25 - +
  • [10] Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States (vol 22, pg 168, 2019)
    Chirikov, V
    Ma, I
    Joshi, N.
    Patel, D.
    Smith, A.
    Giambrone, C.
    Cornelio, N.
    Hashemi, L.
    VALUE IN HEALTH, 2019, 22 (06) : 750 - 750
12345